http://circ.ahajournals.org/content/early/2015/03/20/CIRCULATIONAHA.114.013003.abstract
- Christian J. Hoffmann1;
- Ulrike Harms1;
- Andre Rex1;
- Frank Szulzewsky2;
- Susanne A. Wolf2;
- Ulrike Grittner1;
- Gisela Lättig-Tünnemann1;
- Michael Sendtner3;
- Helmut Kettenmann4;
- Ulrich Dirnagl5;
- Matthias Endres5;
- Christoph Harms1*
+ Author Affiliations
- ↵* Center for Stroke Research, Charité-University Medicine Berlin, Robert-Koch Platz 4, D-10115 Berlin, Germany christoph.harms@charite.de
Abstract
Background—Post-stroke
angiogenesis contributes to long-term recovery after stroke. Signal
transducer and activator of transcription-3
(Stat3) is a key regulator for various
inflammatory signals and angiogenesis. It was the aim of this study to
determine its
function in post stroke outcome.
Methods and Results—We generated a tamoxifen-inducible and endothelial-specific Stat3 knockout mouse model by crossbreeding Stat3floxed/KO and Tie2-CreERT2
mice. Cerebral ischemia was induced by 30 minutes of middle cerebral
artery occlusion (MCAo). We demonstrated that endothelial
Stat3 ablation did not alter lesion size 2 days
after ischemia but did worsen functional outcome at 14 days and increase
lesion
size at 28 days. At this late time point
vascular Stat3 expression and phosphorylation were still increased in
wildtype mice.
Gene array analysis of a CD31-enriched cell
population of the neurovascular niche showed that endothelial Stat3
ablation led
to a shift toward an anti-angiogenic and axon
growth-inhibiting micro-milieu after stroke, with an increased
expression of
Adamts9. Remodeling and glycosylation of the
extracellular matrix (ECM) as well as microglia proliferation were
increased
while angiogenesis was reduced.
Conclusions—Endothelial
Stat3 regulates angiogenesis, axon growth and ECM-remodeling and is
essential for long-term recovery after stroke.
It might serve as a potent target for stroke
treatment after the acute phase by fostering angiogenesis and
neuroregeneration.
No comments:
Post a Comment